Humoral and Cellular Immunity to Varicella-Zoster Virus Glycoprotein gpI and to a Non-glycosylated Protein, p170, in the Strain 2 Guinea-pig

References

1. Arvin A. M., Koropchak C. M. 1980; Immunoglobulins M and G to varicella-zoster virus measured by solid phase radioimmunoassay: antibody responses to varicella and herpes zoster infections. Journal of Clinical Microbiology 12:367–374
   [Google Scholar]
2. Arvin A. M., Martin D. P., Gard E. A., Merigan T. C. 1983; Interferon prophylaxis for simian varicella infection in Erthrocebus patasmonkeys. Journal of Infectious Diseases 147:149–154
   [Google Scholar]
3. Arvin A. M., Kinney-Thomas E., Shriver K., Grose C., Koropchak C. M., Scranton E., Witter A. E., Diaz P. S. 1986; Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118) and to a nonglycosylated protein, p 170. Journal of Immunology 137:1346–1351
   [Google Scholar]
4. Bia F. J., Griffith B. P., Fong C. K. Y., Hsiung G. D. 1983; Cytomegaloviral infections in the guinea pig: experimental models for human disease. Reviews of Infectious Diseases 5:177–195
   [Google Scholar]
5. Davison A. I., Edson C. M., Ellis R. W., Forghani B., Gilden D., Grose C., Keller P. M., Vafai A., Wroblewska Z., Yamanishi K. 1986; A new nomenclature for the glycoprotein genes of varicella-zoster virus and their glycosylated products. Journal of Virology 57:1195–1197
   [Google Scholar]
6. Donnenberg A. D., Bell E., Aurelian L. 1980; Immunity to herpes simplex virus type-2.1. Development of virus-specific lymphoproliferative and leukocyte migration inhibition factor responses in HSV-2 infected guinea-pigs. Cellular Immunology 56:526–539
   [Google Scholar]
7. Edmond B. J., Grose C., Brunell P. A. 1981; Varicella-zoster virus infection of diploid and chemically transformed guinea-pig embryo cells: factors influencing virus replication. Journal of General Virology 54:403–407
   [Google Scholar]
8. Emini E. A., Kao S.-y., Lewis A. J., Crainic R., Wimmer E. 1983; The functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies. Journal of Virology 46:466–474
   [Google Scholar]
9. Friedrichs W. E., Grose C. 1984; Glycoprotein gp 118 of varicella-zoster virus: purification by serial affinity chromatography. Journal of Virology 49:992–996
   [Google Scholar]
10. Gershon A. A., Steinberg S. P., Gelb L., Galasso G., Borkowsky W., Larussa P., Ferarra A. 1984; Live attenuated varicella vaccine: efficacy for children with leukemia in remission. Journal of the American Medical Association 252:355–362
    [Google Scholar]
11. Gonczol E., Hudecz F., Ianacone J., Dietzschold B., Starr S., Plotkin S. A. 1986; Immune responses to isolated human cytomegalovirus envelope proteins. Journal of Virology 58:661–664
    [Google Scholar]
12. Grose C., Friedrichs W. E. 1982; Immunoprecipitable polypeptides specified by varicella-zoster virus. Virology 118:86–95
    [Google Scholar]
13. Ho R. J., Rouse B. T., Huang L. 1986; Target sensitive immunoliposomes: preparation and sensitization. Biochemistry 25:5500–5506
    [Google Scholar]
14. Keller P. M., Neff B. J., Ellis R. W. 1984; Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. Journal of Virology 52:293–297
    [Google Scholar]
15. Keller P. M., Lonergan K., Neff B. J., Morton D. A., Ellis R. W. 1986; Purification of individual varicellazoster virus (VZV) glycoproteins gpl, gpll and gpIII and their use in ELISA for detection of VZV glycoprotein specific antibodies. Journal of Virological Methods 14:177–188
    [Google Scholar]
16. Matsunaga Y., Yamanishi K., Takahashi M. 1982; Experimental infection and immune response of guinea- pigs with varicella-zoster virus. Infection and Immunity 37:407–412
    [Google Scholar]
17. Myers M. G., Stanberry L. R., Edmond B. I. 1985; Varicella-zoster virus infection of strain 2 guinea-pigs. Journal of Infectious Diseases 151:106–113
    [Google Scholar]
18. Rasmussen L. R., Mullenax J., Nelson M., Merigan T. C. 1985; Human cytomegalovirus polypeptides stimulate neutralizing antibody in vivo. Virology 145:186–190
    [Google Scholar]
19. Schrier R. D., Pizer L. I., Moorhead I. W. 1983; Type-specific delayed hypersensitivity and protective immunity induced by isolated herpes simplex virus glycoprotein. Journal of Immunology 130:1413–1418
    [Google Scholar]
20. Townsend A. R. M., Mcmichael A. J., Carter N. P., Huddleston I. A., Brownlee G. G. 1984; Cytotoxic T-cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell 39:13–25
    [Google Scholar]
21. Yewdell J. W., Bennick J. R., Mackett M., Lefrancois L., Lyles D. S., Moss B. 1986; Recognition of clones of vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes. Journal of Experimental Medicine 163:1529–1534
    [Google Scholar]